Literature DB >> 29424246

Increased plasma FGF21 level as an early biomarker for insulin resistance and metabolic disturbance in obese insulin-resistant rats.

Pongpan Tanajak1,2,3, Wanpitak Pongkan1,4, Siriporn C Chattipakorn1,3,5, Nipon Chattipakorn1,2,3.   

Abstract

Propose: To investigate the temporal relationship between plasma fibroblast growth factor 21 levels, insulin resistance, metabolic dysfunction and cardiac fibroblast growth factor 21 resistance in long-term high-fat diet-induced obese rats.
METHODS: In total, 36 male Wistar rats were fed with either a normal diet or high-fat diet for 12 weeks. Blood was collected from the tail tip, and plasma was used to determine metabolic profiles and fibroblast growth factor 21 levels. Rats were sacrificed at weeks 4, 8 and 12, and the hearts were rapidly removed for the determination of cardiac fibroblast growth factor 21 signalling pathways.
RESULTS: Body weight and plasma fibroblast growth factor 21 levels were increased after 4 weeks of consumption of a high-fat diet. At weeks 8 and 12, high-fat diet rats had significantly increased body weight and plasma fibroblast growth factor 21 levels, together with increased plasma insulin, HOMA index, area under the curve of glucose, plasma total cholesterol, plasma low-density lipoprotein cholesterol, serum malondialdehyde and cardiac malondialdehyde levels. However, plasma high-density lipoprotein cholesterol levels and cardiac fibroblast growth factor 21 signalling proteins (p-FGFR1 Tyr154, p-ERK1/2 Thr202/Tyr204 and p-Akt Ser473) were decreased, compared with normal diet rats.
CONCLUSION: These findings suggest that plasma fibroblast growth factor 21 levels could be an early predictive biomarker prior to the development of insulin resistance, metabolic disturbance and cardiac fibroblast growth factor 21 resistance.

Entities:  

Keywords:  Plasma fibroblast growth factor 21 levels; biomarker; cardiac fibroblast growth factor 21 resistance; insulin resistance; metabolic dysfunction; obesity

Mesh:

Substances:

Year:  2018        PMID: 29424246     DOI: 10.1177/1479164118757152

Source DB:  PubMed          Journal:  Diab Vasc Dis Res        ISSN: 1479-1641            Impact factor:   3.291


  6 in total

1.  The relationship of circulating fibroblast growth factor 21 levels with pericardial fat: The Multi-Ethnic Study of Atherosclerosis.

Authors:  Arsenios Magdas; Jingzhong Ding; Robyn L McClelland; Matthew A Allison; Philip J Barter; Kerry-Anne Rye; Kwok Leung Ong
Journal:  Sci Rep       Date:  2019-11-11       Impact factor: 4.379

2.  Omega 3 rich diet modulates energy metabolism via GPR120-Nrf2 crosstalk in a novel antioxidant mouse model.

Authors:  Deborah Amos; Carla Cook; Nalini Santanam
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2019-01-16       Impact factor: 4.698

3.  Association of FGF19, FGF21 and FGF23 with carbohydrate metabolism parameters and insulin resistance in patients with chronic kidney disease.

Authors:  Malgorzata Marchelek-Mysliwiec; Violetta Dziedziejko; Katarzyna Dolegowka; Andrzej Pawlik; Krzysztof Safranow; Joanna Stepniewska; Magda Wisniewska; Jolanta Malyszko; Kazimierz Ciechanowski
Journal:  J Appl Biomed       Date:  2020-02-28       Impact factor: 1.797

4.  Epigenetic Regulation of Processes Related to High Level of Fibroblast Growth Factor 21 in Obese Subjects.

Authors:  Teresa Płatek; Anna Polus; Joanna Góralska; Urszula Raźny; Agnieszka Dziewońska; Agnieszka Micek; Aldona Dembińska-Kieć; Bogdan Solnica; Małgorzata Malczewska-Malec
Journal:  Genes (Basel)       Date:  2021-02-21       Impact factor: 4.096

5.  Mistranslation Drives Alterations in Protein Levels and the Effects of a Synonymous Variant at the Fibroblast Growth Factor 21 Locus.

Authors:  Ali Bayoumi; Asmaa Elsayed; Shuanglin Han; Salvatore Petta; Leon A Adams; Rocio Aller; Anis Khan; Carmelo García-Monzón; María Teresa Arias-Loste; Luca Miele; Olivier Latchoumanin; Shafi Alenizi; Rocio Gallego-Durán; Janett Fischer; Thomas Berg; Antonio Craxì; Mayada Metwally; Liang Qiao; Christopher Liddle; Hannele Yki-Järvinen; Elisabetta Bugianesi; Manuel Romero-Gomez; Jacob George; Mohammed Eslam
Journal:  Adv Sci (Weinh)       Date:  2021-05-01       Impact factor: 16.806

6.  Circulating Diabetic Candidate Neurotrophic Factors, Brain-Derived Neurotrophic Factor and Fibroblast Growth Factor 21, in Sleeve Gastrectomy.

Authors:  Hung-Hsuan Yen; Sung-Tsang Hsieh; Chi-Ling Chen; Wei-Shiung Yang; Po-Chu Lee; Ming-Tsan Lin; Chiung-Nien Chen; Po-Jen Yang
Journal:  Sci Rep       Date:  2020-03-24       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.